# Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder

> **NCT03817931** · PHASE4 · COMPLETED · sponsor: **Baylor Research Institute** · enrollment: 12 (actual)

## Conditions studied

- Overactive Bladder
- Dementia
- Lower Urinary Tract Symptoms
- Incontinence, Urge

## Interventions

- **DRUG:** Anticholinergic
- **DRUG:** Beta-3 Agonists, Adrenergic
- **DIAGNOSTIC_TEST:** Functional magnetic resonance imaging (fMRI)
- **DIAGNOSTIC_TEST:** Rey Auditory Verbal Learning Test (RAVLT)

## Key facts

- **NCT ID:** NCT03817931
- **Lead sponsor:** Baylor Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-05
- **Primary completion:** 2022-02-02
- **Final completion:** 2022-02-26
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2024-02-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03817931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03817931, "Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03817931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*